{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:46:08Z","timestamp":1789011968041,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12020-017-1295-4","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:04:01Z","timestamp":1491955441000},"page":"503-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-0226","authenticated-orcid":false,"given":"Francesco","family":"Fallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso E.","family":"Gomez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Rhayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Maffeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"1295_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0002-9343(77)90883-X","volume":"62","author":"MJ Hogan","year":"1977","unstructured":"M.J. Hogan, M. Schambelan, E.G. Biglieri, Concurrent hypercortisolism and hypermineralocorticoidism. Am. J. Med. 62, 777\u2013782 (1977)","journal-title":"Am. J. Med."},{"key":"1295_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-10-1070","volume":"164","author":"M Sp\u00e4th","year":"2011","unstructured":"M. Sp\u00e4th, S. Korovkin, C. Antke, M. Anlauf, H.S. Willenberg, Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur. J. Endocrinol. 164, 447\u2013455 (2011)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1066896911427036","volume":"20","author":"V Vicennati","year":"2012","unstructured":"V. Vicennati, A. Repaci, G. di Dalmazi, E. Rinaldi, R. Golfieri, E. Giampalma, F. Minni, N. Marrano, D. Santini, R. Pasquali, Combined aldosterone and cortisol secretion by adrenal incidentaloma. Int. J. Surg. Pathol. 20, 316\u2013319 (2012)","journal-title":"Int. J. Surg. Pathol."},{"key":"1295_CR4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","volume":"59","author":"M Yamada","year":"2012","unstructured":"M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735\u2013774 (2012)","journal-title":"Endocr. J."},{"key":"1295_CR5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","volume":"29","author":"F Fallo","year":"2011","unstructured":"F. Fallo, C. Bertello, D. Tizzani, A. Fassina, S. Boulkroun, N. Sonino, S. Monticone, A. Viola, F. Veglio, P. Mulatero, Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J. Hypertens. 29, 1773\u20131777 (2011)","journal-title":"J. Hypertens."},{"key":"1295_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","volume":"58","author":"K Hiraishi","year":"2011","unstructured":"K. Hiraishi, T. Yoshimoto, K. Tsuchiya, I. Minami, M. Doi, H. Izumiyama, H. Sasano, Y. Hirata, Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome. Endocr. J. 58, 543\u2013551 (2011)","journal-title":"Endocr. J."},{"key":"1295_CR7","first-page":"130042","volume":"2013","author":"V Yoon","year":"2013","unstructured":"V. Yoon, A. Heyliger, T. Maekawa, H. Sasano, K. Carrick, S. Woodruff, J. Rabaglia, R.J. Auchus, H.K. Ghayee, Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids. Endocrinol. Diabetes Metab. Case Rep. 2013, 130042 (2013)","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"1295_CR8","first-page":"564","volume":"36","author":"K Fujimoto","year":"2013","unstructured":"K. Fujimoto, S. Honjo, H. Tatsuoka, Y. Hamamoto, Y. Kawasaki, A. Matsuoka, H. Ikeda, Y. Wada, H. Sasano, H. Koshiyama, Primary aldosteronism associated with subclinical Cushing syndrome. J. Endocrinol. Invest. 36, 564\u2013567 (2013)","journal-title":"J. Endocrinol. Invest."},{"key":"1295_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3904\/kjim.2014.29.5.679","volume":"29","author":"KY Chang","year":"2014","unstructured":"K.Y. Chang, S. Ryu, J.Y. Cho, H.W. Kim, Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome. Korean J. Intern. Med. 29, 679\u2013682 (2014)","journal-title":"Korean J. Intern. Med."},{"key":"1295_CR10","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","volume":"96","author":"Y Nakajima","year":"2011","unstructured":"Y. Nakajima, M. Yamada, R. Taguchi, T. Satoh, K. Hashimoto, A. Ozawa, N. Shibusawa, S. Okada, T. Monden, M. Mori, Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J. Clin. Endocrinol. Metab. 96, 2512\u20132518 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0035-1565124","volume":"47","author":"A Prejbisz","year":"2015","unstructured":"A. Prejbisz, E. Warcho\u0142-Celi\u0144ska, J.W. Lenders, A. Januszewicz, Cardiovascular risk in rimary hyperaldosteronism. Horm. Metab. Res. 47, 973\u2013980 (2015)","journal-title":"Horm. Metab. Res."},{"key":"1295_CR12","doi-asserted-by":"crossref","first-page":"M61","DOI":"10.1530\/EJE-15-0272","volume":"173","author":"G Dalmazi Di","year":"2015","unstructured":"G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61\u2013M71 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2265.2009.03551.x","volume":"71","author":"GP Piaditis","year":"2009","unstructured":"G.P. Piaditis, G.A. Kaltsas, I.I. Androulakis, A. Gouli, P. Makras, D. Papadogias, K. Dimitriou, D. Ragkou, A. Markou, K. Vamvakidis, G. Zografos, G. Chrousos, High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin. Endocrinol. (Oxf). 71, 772\u2013778 (2009)","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"1295_CR14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mce.2014.09.015","volume":"399","author":"S Monticone","year":"2015","unstructured":"S. Monticone, T. Else, P. Mulatero, T.A. Williams, W.E. Rainey, Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol. Cell. Endocrinol. 399, 311\u2013320 (2015)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1295_CR15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","volume":"83","author":"UI Scholl","year":"2015","unstructured":"U.I. Scholl, J.M. Healy, A. Thiel, A.L. Fonseca, T.C. Brown, J.W. Kunstman, M.J. Horne, D. Dietrich, J. Riemer, S. K\u00fcc\u00fckk\u00f6yl\u00fc, E.N. Reimer, A.C. Reis, G. Goh, G. Kristiansen, A. Mahajan, R. Korah, R.P. Lifton, M.L. Prasad, T. Carling, Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin. Endocrinol. (Oxf). 83, 779\u2013789 (2015)","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"1295_CR16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","volume":"373","author":"AE Teo","year":"2015","unstructured":"A.E. Teo, S. Garg, L.H. Shaikh, J. Zhou, F.E. Karet Frankl, M. Gurnell, L. Happerfield, A. Marker, M. Bienz, E.A. Azizan, M.J. Brown, Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373, 1429\u20131436 (2015)","journal-title":"N. Engl. J. Med."},{"key":"1295_CR17","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","volume":"6","author":"T \u00c5kerstr\u00f6m","year":"2016","unstructured":"T. \u00c5kerstr\u00f6m, R. Maharjan, H. Sven Willenberg, K. Cupisti, J. Ip, A. Moser, P. St\u00e5lberg, B. Robinson, K. Alexander Iwen, H. Dralle, M.K. Walz, H. Lehnert, S. Sidhu, C. Gomez-Sanchez, P. Hellman, P. Bj\u00f6rklund, Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci. Rep. 6, 19546 (2016)","journal-title":"Sci. Rep."},{"key":"1295_CR18","doi-asserted-by":"crossref","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","volume":"99","author":"G Dalmazi Di","year":"2014","unstructured":"G. Di Dalmazi, C. Kisker, D. Calebiro, M. Mannelli, L. Canu, G. Arnaldi, M. Quinkler, N. Rayes, A. Tabarin, M. Laure Julli\u00e9, F. Mantero, B. Rubin, J. Waldmann, D.K. Bartsch, R. Pasquali, M. Lohse, B. Allolio, M. Fassnacht, F. Beuschlein, M. Reincke, Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093\u2013E2100 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","volume":"172","author":"A Thiel","year":"2015","unstructured":"A. Thiel, A.C. Reis, M. Haase, G. Goh, M. Schott, H.S. Willenberg, U.I. Scholl, PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. Eur. J. Endocrinol. 172, 677\u2013685 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","volume":"59","author":"M Yamada","year":"2012","unstructured":"M. Yamada, Y. Nakajima, R. Taguchi, T. Okamura, S. Ishii, T. Tomaru, A. Ozawa, N. Shibusawa, S. Yoshino, A. Toki, E. Ishida, K. Hashimoto, T. Satoh, M. Mori, KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas. Endocr. J. 59, 735\u2013741 (2012)","journal-title":"Endocr. J."},{"key":"1295_CR21","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","volume":"101","author":"Y Rhayem","year":"2016","unstructured":"Y. Rhayem, L.G. Perez-Rivas, A. Dietz, K. Bathon, C. Gebhard, A. Riester, B. Mauracher, C. Gomez-Sanchez, G. Eisenhofer, T. Schwarzmayr, D. Calebiro, T.M. Strom, M. Reincke, F. Beuschlein, PRKACA somatic mutations are rare findings in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 101, 3010\u20133017 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young Jr., The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/cen.12750","volume":"83","author":"R Goupil","year":"2015","unstructured":"R. Goupil, M. Wolley, A.H. Ahmed, R.D. Gordon, M. Stowasser, Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism ? Clin. Endocrinol. (Oxf). 83, 456\u2013461 (2015)","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"1295_CR24","doi-asserted-by":"publisher","unstructured":"M. Kishino, T. Yoshimoto, M. Nakadate, Y. Katada, E. Kanda, S. Nakaminato, Y. Saida, Y. Ogawa, U. Tateishi, Optimization of left adrenal vein sampling in primary aldosteronism: coping with asymmetrical cortisol secretion. Endocr. J. (2017). doi:\n                        10.1507\/endocrj.EJ16-0433\n                        \n                    . PubMed PMID: 28132968","DOI":"10.1507\/endocrj.EJ16-0433"},{"key":"1295_CR25","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","volume":"83","author":"P Mulatero","year":"1998","unstructured":"P. Mulatero, F. Veglio, C. Pilon, F. Rabbia, C. Zocchi, P. Limone, M. Boscaro, N. Sonino, F. Fallo, Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J. Clin. Endocrinol. Metab. 83, 2573\u20132575 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR27","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","volume":"91","author":"P Mulatero","year":"2006","unstructured":"P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, M. Maccario, Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 91, 2618\u20132623 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR28","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","volume":"33","author":"J Manolopoulou","year":"2015","unstructured":"J. Manolopoulou, E. Fischer, A. Dietz, S. Diederich, D. Holmes, R. Junnila, P. Grimminger, M. Reincke, A. Morganti, M. Bidlingmaier, Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J. Hypertens. 33, 2500\u20132511 (2015)","journal-title":"J. Hypertens."},{"key":"1295_CR29","unstructured":"M.T. Moonim, S.J. Johnson, A.M. McNicol. Cancer dataset for the histological reporting of adrenal cortical carcinoma and phaeochromocytoma\/paraganglioma (2nd edition). \n                        https:\/\/www.rcpath.org\/resourceLibrary\/g109_adrenaldataset_jan12-pdf.html\n                        \n                     (2012)."},{"key":"1295_CR30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0300-595X(85)80078-5","volume":"14","author":"AM Neville","year":"1985","unstructured":"A.M. Neville, M.J. O\u2019Hare, Histopathology of the human adrenal cortex. Clin. Endocrinol. Metab. 14, 791\u2013820 (1985).","journal-title":"Clin. Endocrinol. Metab."},{"key":"1295_CR31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/pin.12200","volume":"64","author":"Y Nakamura.","year":"2014","unstructured":"Y. Nakamura., S.J. Felizola, F. Satoh, S. Konosu-Fukaya, H. Sasano, Dissecting the molecular pathways of primary aldosteronism. Pathol. Int. 64, 482\u2013489 (2014)","journal-title":"Pathol. Int."},{"key":"1295_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","volume":"383","author":"CE Gomez-Sanchez","year":"2014","unstructured":"C.E. Gomez-Sanchez, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, C.R. Parker, W. Rainey, F. Satoh, T. Maekawa, Y. Nakamura, H. Sasano, E.P. Gomez-Sanchez, Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol. Cell. Endocrinol. 383, 111\u2013117 (2014)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1295_CR33","first-page":"716","volume":"109","author":"KS McCarty Jr.","year":"1985","unstructured":"K.S. McCarty Jr., L.S. Miller, E.B. Cox, J. Konrath, K.S. McCarty Sr., Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716\u2013721 (1985)","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1295_CR34","first-page":"5419","volume":"46","author":"DA Budwit-Novotny","year":"1986","unstructured":"D.A. Budwit-Novotny, K.S. McCarty, E.B. Cox, J.T. Soper, D.G. Mutch, W.T. Creasman, I.L. Flowers, K.S. McCarty Jr., Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46, 5419\u20135425 (1986)","journal-title":"Cancer Res."},{"key":"1295_CR35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/HYPERTENSIONAHA.113.02944","volume":"64","author":"Y Ono","year":"2014","unstructured":"Y. Ono, Y. Nakamura, T. Maekawa, S.J. Felizola, R. Morimoto, Y. Iwakura, M. Kudo, K. Seiji, K. Takase, Y. Arai, C.E. Gomez-Sanchez, S. Ito, H. Sasano, F. Satoh, Different expression of 11\u03b2-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension 64, 438\u2013444 (2014)","journal-title":"Hypertension"},{"key":"1295_CR36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","volume":"64","author":"FL Fernandes-Rosa","year":"2014","unstructured":"F.L. Fernandes-Rosa, T.A. Williams, A. Riester, O. Steichen, F. Beuschlein, S. Boulkroun, T.M. Strom, S. Monticone, L. Amar, Y. Meatchi, F. Mantero, M.V. Cicala, M. Quinkler, F. Fallo, B. Allolio, G. Bernini, M. Maccario, G. Giacchetti, X. Jeunemaitre, P. Mulatero, M. Reincke, M.C. Zennaro, Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354\u2013361 (2014)","journal-title":"Hypertension"},{"key":"1295_CR37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","volume":"63","author":"TA Williams","year":"2014","unstructured":"T.A. Williams, S. Monticone, V.R. Schack, J. Stindl, J. Burrello, F. Buffolo, L. Annaratone, I. Castellano, F. Beuschlein, M. Reincke, B. Lucatello, V. Ronconi, F. Fallo, G. Bernini, M. Maccario, G. Giacchetti, F. Veglio, R. Warth, B. Vilsen, P. Mulatero, Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension 63, 188\u2013195 (2014)","journal-title":"Hypertension"},{"key":"1295_CR38","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","volume":"96","author":"S Bonnet","year":"2011","unstructured":"S. Bonnet, S. Gaujoux, P. Launay, C. Baudry, I. Chokri, B. Ragazzon, R. Lib\u00e9, F. Ren\u00e9-Corail, A. Audebourg, M.C. Vacher-Lavenu, L. Groussin, X. Bertagna, B. Dousset, J. Bertherat, F. Tissier, Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J. Clin. Endocrinol. Metab. 96, E419\u2013E426 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/eje.0.1470795","volume":"147","author":"F Fallo","year":"2002","unstructured":"F. Fallo, V. Pezzi, L. Barzon, P. Mulatero, F. Veglio, N. Sonino, J.M. Mathis, Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur. J. Endocrinol. 147, 795\u2013802 (2002)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR40","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1253\/circj.69.1425","volume":"69","author":"H Fujii","year":"2005","unstructured":"H. Fujii, K. Kamide, O. Miyake, T. Abe, M. Nagai, H. Nakahama, T. Horio, S. Takiuchi, A. Okuyama, C. Yutani, Y. Kawano, Primary aldosteronism combined with preclinical Cushing\u2019s syndrome in an elderly patient. Circ. J. 69, 1425\u20131427 (2005)","journal-title":"Circ. J."},{"key":"1295_CR41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","volume":"392","author":"Y Nakamura","year":"2014","unstructured":"Y. Nakamura, T. Maekawa, S.J. Felizola, F. Satoh, X. Qi, C. Velarde-Miranda, M.W. Plonczynski, K. Ise, K. Kikuchi, W.E. Rainey, E.P. Gomez-Sanchez, C.E. Gomez-Sanchez, H. Sasano, Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies. Mol. Cell. Endocrinol. 392, 73\u201379 (2014)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1295_CR42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","volume":"411","author":"S Monticone","year":"2015","unstructured":"S. Monticone, I. Castellano, K. Versace, B. Lucatello, F. Veglio, C.E. Gomez-Sanchez, T.A. Williams, P. Mulatero, Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol. Cell. Endocrinol. 411, 146\u2013154 (2015)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1295_CR43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.107.100438","volume":"50","author":"L Lenzini","year":"2007","unstructured":"L. Lenzini, T.M. Seccia, E. Aldighieri, A.S. Belloni, P. Bernante, L. Giuliani, G.G. Nussdorfer, A.C. Pessina, G.P. Rossi, Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50, 1106\u20131113 (2007)","journal-title":"Hypertension"},{"key":"1295_CR44","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","volume":"99","author":"T Dekkers","year":"2014","unstructured":"T. Dekkers, M. ter Meer, J.W. Lenders, A.R. Hermus, L.S. Kool, J.F. Langenhuijsen, K. Nishimoto, T. Ogishima, K. Mukai, E.A. Azizan, B. Tops, J. Deinum, B. K\u00fcsters, Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J. Clin. Endocrinol. Metab. 99, E1341\u2013E1351 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR45","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","volume":"97","author":"EA Azizan","year":"2012","unstructured":"E.A. Azizan, B.Y. Lam, S.J. Newhouse, J. Zhou, R.E. Kuc, J. Clarke, L. Happerfield, A. Marker, G.J. Hoffman, M.J. Brown, Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J. Clin. Endocrinol. Metab. 97, E819\u2013E829 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fendo.2016.00075","volume":"7","author":"E Seidel","year":"2016","unstructured":"E. Seidel, U.I. Scholl, Intracellular molecular differences in aldosterone-compared to cortisol-secreting adrenal cortical adenomas. Front Endocrinol (Lausanne). 7, 75 (2016). doi:\n                        10.3389\/fendo.2016.00075\n                        \n                    . Review","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1295_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-15-0324","volume":"57","author":"NG Hattangady","year":"2016","unstructured":"N.G. Hattangady, S. Karashima, L. Yuan, D. Ponce-Balbuena, J. Jalife, C.E. Gomez- Sanchez, R.J. Auchus, W.E. Rainey, T. Else, Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production. J. Mol. Endocrinol. 57, 1\u201311 (2016)","journal-title":"J. Mol. Endocrinol."},{"key":"1295_CR48","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1210\/jc.2016-1504","volume":"101","author":"A Tong","year":"2016","unstructured":"A. Tong, G. Liu, F. Wang, J. Jiang, Z. Yan, D. Zhang, Y. Zhang, J. Cai, A novel phenotype of familial hyperaldosteronism Type III: concurrence of aldosteronism and Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 101, 4290\u20134297 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.1254901","volume":"344","author":"LS Kirschner","year":"2014","unstructured":"L.S. Kirschner, Medicine. A unified cause of adrenal Cushing\u2019s syndrome. Science 344, 804\u2013805 (2014)","journal-title":"Science"},{"key":"1295_CR50","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"F. Beuschlein, M. Fassnacht, G. Assi\u00e9, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N. Engl. J. Med. 370, 1019\u20131028 (2014)","journal-title":"N. Engl. J. Med."},{"key":"1295_CR51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1507\/endocrj.EJ14-0282","volume":"61","author":"Y Nakajima","year":"2014","unstructured":"Y. Nakajima, T. Okamura, T. Gohko, T. Satoh, K. Hashimoto, N. Shibusawa, A. Ozawa, S. Ishii, T. Tomaru, K. Horiguchi, S. Okada, D. Takata, N. Rokutanda, J. Horiguchi, Y. Tsushima, T. Oyama, I. Takeyoshi, M. Yamada, Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr. J. 61, 825\u2013832 (2014)","journal-title":"Endocr. J."},{"key":"1295_CR52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2010.11.014","volume":"332","author":"A El Wakil","year":"2011","unstructured":"A. El Wakil, E. Lalli, The Wnt\/beta-catenin pathway in adrenocortical development and cancer. Mol. Cell. Endocrinol. 332, 32\u201337 (2011)","journal-title":"Mol. Cell. Endocrinol."},{"key":"1295_CR53","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","volume":"275","author":"PJ Morin","year":"1997","unstructured":"P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, K.W. Kinzler, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787\u20131790 (1997)","journal-title":"Science"},{"key":"1295_CR54","doi-asserted-by":"crossref","first-page":"39121","DOI":"10.1038\/srep39121","volume":"7","author":"VC Wu","year":"2017","unstructured":"V.C. Wu, S.M. Wang, S.J. Chueh, S.Y. Yang, K.H. Huang, Y.H. Lin, J.J. Wang, R. Connolly, Y.H. Hu, C.E. Gomez-Sanchez, K.Y. Peng, K.D. Wu, The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Sci. Rep. 7, 39121 (2017)","journal-title":"Sci. Rep."},{"key":"1295_CR55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"C. Liu, Y. Li, M. Semenov, C. Han, G.H. Baeg, Y. Tan, Z. Zhang, X. Lin, X. He, Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell 108, 837\u2013847 (2002)","journal-title":"Cell"},{"key":"1295_CR56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0006-291X(02)00485-0","volume":"294","author":"T Hagen","year":"2002","unstructured":"T. Hagen, A. Vidal-Puig, Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem. Biophys. Res. Commun. 294, 324\u2013328 (2002)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1295_CR57","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/onc.2010.202","volume":"29","author":"CH Wilson","year":"2010","unstructured":"C.H. Wilson, R.E. McIntyre, M.J. Arends, D.J. Adams, The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc (Min\/ +) mice through activation of Wnt and ERK1\/2 MAPK pathways. Oncogene 29, 4567\u20134575 (2010)","journal-title":"Oncogene"},{"key":"1295_CR58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","volume":"63","author":"Y Nakajima","year":"2016","unstructured":"Y. Nakajima, T. Okamura, K. Horiguchi, T. Gohko, T. Miyamoto, T. Satoh, A. Ozawa, S. Ishii, E. Yamada, K. Hashimoto, S. Okada, D. Takata, J. Horiguchi, M. Yamada, GNAS mutations in adrenal aldosterone-producing adenomas. Endocr. J. 63, 199\u2013204 (2016)","journal-title":"Endocr. J."},{"key":"1295_CR59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","volume":"9","author":"L Cazabat","year":"2006","unstructured":"L. Cazabat, B. Ragazzon, L. Groussin, J. Bertherat, PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary 9, 211\u2013219 (2006)","journal-title":"Pituitary"},{"key":"1295_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcell.2015.00026","volume":"3","author":"AS Berthon","year":"2015","unstructured":"A.S. Berthon, E. Szarek, C.A. Stratakis, PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors. Front. Cell. Dev. Biol. 3, 26 (2015). doi:\n                        10.3389\/fcell.2015.00026","journal-title":"Front. Cell. Dev. Biol."},{"key":"1295_CR61","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2014-3295","volume":"99","author":"CA Stratakis","year":"2014","unstructured":"C.A. Stratakis, E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors. J. Clin. Endocrinol. Metab. 99, 3629\u20133633 (2014). Erratum in: J. Clin. Endocrinol. Metab. 100, 764 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","volume":"4","author":"JA Carney","year":"2015","unstructured":"J.A. Carney, C. Lyssikatos, M.B. Lodish, C.A. Stratakis, Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. Hum. Pathol. 46, 40\u201349 (2015)","journal-title":"Hum. Pathol."},{"key":"1295_CR63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","volume":"172","author":"MB Lodish","year":"2015","unstructured":"M.B. Lodish, B. Yuan, I. Levy, G.D. Braunstein, C. Lyssikatos, P. Salpea, E. Szarek, A.S. Karageorgiadis, E. Belyavskaya, M. Raygada, F.R. Faucz, L. Izatt, C. Brain, J. Gardner, M. Quezado, J.A. Carney, J.R. Lupski, C.A. Stratakis, Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Eur. J. Endocrinol. 172, 803\u2013811 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR64","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem.84.3.5549","volume":"84","author":"CA Stratakis","year":"1999","unstructured":"C.A. Stratakis, J.A. Carney, L.S. Kirschner, H.S. Willenberg, S. Brauer, M. Ehrhart-Bornstein, S.R. Bornstein, Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J. Clin. Endocrinol. Metab. 84, 1122\u20131128 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1295_CR65","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0000000000000220","volume":"38","author":"JA Carney","year":"2014","unstructured":"J.A. Carney, R. Lib\u00e9, J. Bertherat, W.F. Young, Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings. Am. J. Surg. Pathol. 38, 1266\u20131273 (2014)","journal-title":"Am. J. Surg. Pathol."},{"key":"1295_CR66","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/EJE-09-0596","volume":"161","author":"K Shigematsu","year":"2009","unstructured":"K. Shigematsu, N. Nishida, H. Sakai, T. Igawa, K. Toriyama, A. Nakatani, O. Takahara, K. Kawai, Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression. Eur. J. Endocrinol. 161, 939\u2013945 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"1295_CR67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0b013e3181cfb506","volume":"34","author":"AR Sangoi","year":"2010","unstructured":"A.R. Sangoi, J.K. McKenney, A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am. J. Surg. Pathol. 34, 423\u2013432 (2010)","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1295-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1295-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1295-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T11:30:20Z","timestamp":1510918220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1295-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1295-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}